Clinical Trials · NCT07662213

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Name: A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 3Semaglutide

Phase: Phase 3
Recruitment status: Recruiting
Sponsor: AstraZeneca
Enrollment: 1,200
Start date: Jul 2026
Locations: 201 sites, 15 countries
Primary endpoint: Change from baseline in Hemoglobin A1c (HbA1c)

View Semaglutide compound reference